Evidence map›Paper›PMID 39727969›Full record

ReviewCurrent issues in molecular biology2024

YBX1: A Multifunctional Protein in Senescence and Immune Regulation.

Wenze Zhang, Ying Liu, Zhe Zhao, Yizhi Zhang, Yujuan Liang, Wanxia Wang

Abstract readReview
In one paragraph

Review in Current issues in molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Screening of CCDC43 molecular partners by BioID2-based proximity labeling.Turkish journal of biology = Turk biyoloji dergisi · 2025
    Article
  18. YBX1/CD36 positive feedback loop: novel molecular target for MASLD treatment.International journal of biological sciences · 2025
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenze ZhangThe First College of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.ORCID 0009-0004-3057-5187
Ying LiuThe First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China.ORCID 0009-0002-7484-1251
Zhe ZhaoThe First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China.ORCID 0009-0006-8174-5160
Yizhi ZhangThe First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China.ORCID 0009-0004-3449-638X
Yujuan LiangThe First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China.ORCID 0009-0005-6182-3232
Wanxia WangThe First College of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.ORCID 0000-0002-9008-6324

Funding

Gansu Provincial Health Commission GSMSON2021-004Gansu Provincial People's Hospital 23GSSYA-7
6 · The paper itself

Abstract

The Y-box binding protein 1 (YBX1) is a multifunctional protein with a wide range of roles in cell biology. It plays a crucial role in immune modulation, senescence, and disease progression. This review presents a comprehensive analysis of the specific functions and mechanisms of YBX1 in these areas. Initially, YBX1 is shown to be closely associated with cellular senescence and impacts significant biological processes, including cell proliferation, damage repair, and metabolism. This suggests potential applications in the prevention and treatment of senescence-related diseases. Additionally, YBX1 regulates the immune response by controlling the function of immune cells and the expression of immune molecules. It is essential in maintaining immune system homeostasis and impacts the pathological process of various diseases, including tumors. Lastly, the diverse functions of the YBX1 protein make it a promising candidate for the development of innovative therapeutic strategies for diseases. Comprehensive research on its mechanisms could provide novel insights and approaches for the prevention, diagnosis, and treatment of related diseases.

Indexed as

cellular senescenceimmunotherapytumor immunityYBX1

Identifiers

PMID39727969
PMCPMC11726992

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.